Article
ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Cell death & disease - 17 Apr 2024
Lee Cheol-Jung, Lee Heejung, Kim Seo Ree, Nam Soo-Bin, Lee Ga-Eun, Yang Kyeong Eun, Lee Guk Jin, Chun Sang Hoon, Kang Han Chang, Lee Joo Young, Lee Hye Suk, Cho Sung-Jun, Cho Yong-Yeon
Abstract excerpt
Accumulating evidence demonstrates that the activity regulation of ELK3, a member of the E26 transformation-specific oncogene family, is critical to regulating cell proliferation, migration, and survival in human cancers. However, the molecular mechanisms of how ELK3 induces chemoresistance in prostate cancer (PCa) have not been elucidated. In this study, we found that SPOP and ELK3 are an interacting partner....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
